Back

NeuroThera publishes three U.S. patent applications for PEA and psychoactive-drug combinations

Verifying
  • NeuroThera published three U.S. patent applications covering PEA combinations with LSD, ketamine and ibogaine.
  • Three applications address potential uses in depression, PTSD, pain and substance use disorders.
  • The filings build on an earlier application covering MDMA and N-acylethanolamines for PTSD, anxiety and eating disorders.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.